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Systemic injection of lipopolysaccharide (LPS) produces a doserelated anorexia (22) widely held to reflect the direct action of circulating and brain perivascular mediators (e.g., cytokines, prostaglandins) on CNS circuits (e.g., 13, 25, 12, 21, 2, 9) . induces a dose-related inhibition of feeding (20, 23, 14) . In addition, stimulation of endogenous GLP-1 activity has been implicated in the mediation of the anorexic effects of LiCl, and oxytocin (14, 16, 19) . In each case, doses that reduce food intake increase c- Louis, MO; 100 ug/kg body weight in saline vehicle [1.0 ml/kg]). The last condition for a second group (n=8) was a 4 th -i.c.v. vehicle injection followed by LPS. Groups were weight matched for body weight.
Materials and Methods

Subjects
Tolerance to the ingestive effects of LPS (7) precluded a within-subject comparison of these two injection conditions. The LPS dose selected is commonly tested, e.g., (7, 15) conditions. LPS anorexia was evaluated by within-subjects comparison of vehicle + vehicle and Vehicle + LPS conditions. The ability of the antagonist to attenuate the effect of LPS was evaluated by betweensubject comparison of Vehicle + LPS and Exendin + LPS conditions. In addition, within-subjects differences between Vehicle + Vehicle and Exendin + LPS conditions were also evaluated.
Results
Experiment 1. 
